Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2019-08-29 | 2020-01-30 | 92663 |
| TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2025-05-05 | 2025-05-08 | 256702 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-01 | 2021-04-08 | 136759 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141113 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124998 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2021-06-24 | 2021-07-15 | 141486 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107967 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120893 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-06-24 | 2021-12-01 | 141483 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-12-17 | 2022-12-02 | 151381 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2025-03-06 | 2025-05-08 | 252078 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-02-11 | 2021-03-04 | 133785 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-25 | 132666 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-02-11 | 2021-02-25 | 133788 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136326 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137209 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |